StockNews.com Initiates Coverage on Mannatech (NASDAQ:MTEX)

Research analysts at StockNews.com began coverage on shares of Mannatech (NASDAQ:MTEX) in a research note issued to investors on Tuesday. The firm set a “buy” rating on the stock.

Mannatech Trading Down 1.8 %

MTEX opened at $8.35 on Tuesday. Mannatech has a twelve month low of $7.50 and a twelve month high of $15.93. The company has a quick ratio of 0.51, a current ratio of 1.07 and a debt-to-equity ratio of 0.09. The company has a fifty day moving average of $8.68 and a 200-day moving average of $8.84. The stock has a market cap of $15.69 million, a PE ratio of -6.95 and a beta of 1.20.

Institutional Investors Weigh In On Mannatech

A hedge fund recently raised its stake in Mannatech stock. LSV Asset Management lifted its position in shares of Mannatech, Incorporated (NASDAQ:MTEX) by 1,090.3% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,142 shares of the company’s stock after buying an additional 6,542 shares during the quarter. LSV Asset Management owned about 0.37% of Mannatech worth $261,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 12.98% of the company’s stock.

About Mannatech

Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels.